GlassScriptPhysician profile
Lydia J Lowder
NPI 1275889099
$3,945.19
in general payments reported to CMS, 2019-2025
8 companies · $774 in 2025
The $774 reported for 2025 was more than what 82% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,719 · 2022: $828 · 2023: $151 · 2024: $473 · 2025: $774.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,397.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,397.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,298.98 | 2021-2023 | |
| Novartis Pharmaceuticals Corporation | $1,097.46 | 2021-2025 | |
| E.R. Squibb & Sons, L.L.C. | $608.17 | 2022-2025 | Camzyos, Eliquis |
| Abbott Laboratories | $480.73 | 2021-2025 | Cardiomems, Thoratec Heartmate 3 Lvas Implant Kit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $153.27 | 2022-2023 | Jardiance |
| Pfizer INC. | $143.97 | 2021-2024 | |
| Boston Scientific Corporation | $124.17 | 2021 | |
| Abiomed | $38.44 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lydia Lowder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.